Brent Van Rite, Ph.D. - Publications
Affiliations: | 2012 | College of Engineering | University of Oklahoma, Norman, OK, United States |
Area:
Biomedical Engineering, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Van Rite BD, Krais JJ, Cherry M, Sikavitsas VI, Kurkjian C, Harrison RG. Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature. Cancer Investigation. 31: 505-10. PMID 24083814 DOI: 10.3109/07357907.2013.840383 | 0.672 | |||
2013 | Neves LF, Krais JJ, Van Rite BD, Ramesh R, Resasco DE, Harrison RG. Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy. Nanotechnology. 24: 375104. PMID 23975064 DOI: 10.1088/0957-4484/24/37/375104 | 0.646 | |||
2013 | Krais J, Van Rite B, Kurkjian C, Harrison R. Evaluation of three vascular-targeted enzyme prodrug systems for breast cancer therapy Food, Pharmaceutical and Bioengineering Division 2013 - Core Programming Area At the 2013 Aiche Annual Meeting: Global Challenges For Engineering a Sustainable Future. 223. | 0.554 | |||
2011 | Prickett WM, Van Rite BD, Resasco DE, Harrison RG. Vascular targeted single-walled carbon nanotubes for near-infrared light therapy of cancer. Nanotechnology. 22: 455101. PMID 21993223 DOI: 10.1088/0957-4484/22/45/455101 | 0.683 | |||
2011 | Van Rite BD, Harrison RG. Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine. Cancer Letters. 307: 53-61. PMID 21546157 DOI: 10.1016/j.canlet.2011.03.016 | 0.746 | |||
2011 | Van Rite BD, Lazrak YA, Pagnon ML, Palwai NR, Neves LF, McFetridge PS, Harrison RG. Enzyme prodrug therapy designed to target L-methioninase to the tumor vasculature. Cancer Letters. 301: 177-84. PMID 21194833 DOI: 10.1016/J.Canlet.2010.11.013 | 0.346 | |||
Show low-probability matches. |